| Prevalence, characteristics, and publication of discontinued randomized trials B Kasenda, E Von Elm, J You, A Blümle, Y Tomonaga, R Saccilotto, ... Jama 311 (10), 1045-1052, 2014 | 366 | 2014 |
| Effect of offering same-day ART vs usual health facility referral during home-based HIV testing on linkage to care and viral suppression among adults with HIV in Lesotho: the … ND Labhardt, I Ringera, TI Lejone, T Klimkait, J Muhairwe, A Amstutz, ... Jama 319 (11), 1103-1112, 2018 | 271 | 2018 |
| Subgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publications B Kasenda, S Schandelmaier, X Sun, E Von Elm, J You, A Blümle, ... Bmj 349, 2014 | 116 | 2014 |
| Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials A Amstutz, B Speich, F Mentré, CS Rueegg, D Belhadi, L Assoumou, ... The Lancet Respiratory Medicine 11 (5), 453-464, 2023 | 101 | 2023 |
| Planning and reporting of quality-of-life outcomes in cancer trials S Schandelmaier, K Conen, E Von Elm, JJ You, A Blümle, Y Tomonaga, ... Annals of Oncology 26 (9), 1966-1973, 2015 | 69 | 2015 |
| Completion and publication rates of randomized controlled trials in surgery: an empirical study R Rosenthal, B Kasenda, S Dell-Kuster, E Von Elm, J You, A Blümle, ... Annals of surgery 262 (1), 68-73, 2015 | 62 | 2015 |
| The viral load monitoring cascade in a resource-limited setting: a prospective multicentre cohort study after introduction of routine viral load monitoring in rural Lesotho TR Glass, L Motaboli, B Nsakala, M Lerotholi, F Vanobberghen, A Amstutz, ... PLoS One 14 (8), e0220337, 2019 | 59 | 2019 |
| Learning from failure-rationale and design for a study about discontinuation of randomized trials (DISCO study) B Kasenda, EB von Elm, J You, A Blümle, Y Tomonaga, R Saccilotto, ... BMC medical research methodology 12, 1-10, 2012 | 45 | 2012 |
| Discontinuation and non-publication of randomised clinical trials supported by the main public funding body in Switzerland: a retrospective cohort study A Amstutz, S Schandelmaier, R Frei, J Surina, A Agarwal, KK Olu, ... BMJ open 7 (7), e016216, 2017 | 43 | 2017 |
| Nonregistration, discontinuation, and nonpublication of randomized trials: A repeated metaresearch analysis B Speich, D Gryaznov, JW Busse, VL Gloy, S Lohner, K Klatte, ... PLoS Medicine 19 (4), e1003980, 2022 | 34 | 2022 |
| Switch to second-line versus continued first-line antiretroviral therapy for patients with low-level HIV-1 viremia: an open-label randomized controlled trial in Lesotho A Amstutz, BL Nsakala, F Vanobberghen, J Muhairwe, TR Glass, ... PLoS medicine 17 (9), e1003325, 2020 | 31 | 2020 |
| Premature discontinuation of pediatric randomized controlled trials: a retrospective cohort study S Schandelmaier, Y Tomonaga, D Bassler, JJ Meerpohl, E Von Elm, ... The Journal of pediatrics 184, 209-214. e1, 2017 | 31 | 2017 |
| Premature discontinuation of randomized trials in critical and emergency care: a retrospective cohort study S Schandelmaier, E Von Elm, JJ You, A Blümle, Y Tomonaga, ... Critical care medicine 44 (1), 130-137, 2016 | 31 | 2016 |
| Viral suppression after transition from nonnucleoside reverse transcriptase inhibitor‐to dolutegravir‐based antiretroviral therapy: A prospective cohort study in Lesotho (DO … JA Brown, BL Nsakala, K Mokhele, I Rakuoane, J Muhairwe, L Urda, ... HIV medicine 23 (3), 287-293, 2022 | 29 | 2022 |
| An analysis of protocols and publications suggested that most discontinuations of clinical trials were not based on preplanned interim analyses or stopping rules M Stegert, B Kasenda, E von Elm, JJ You, A Blümle, Y Tomonaga, ... Journal of clinical epidemiology 69, 152-160, 2016 | 27 | 2016 |
| Home-based oral self-testing for absent and declining individuals during a door-to-door HIV testing campaign in rural Lesotho (HOSENG): a cluster-randomised trial A Amstutz, TI Lejone, L Khesa, J Muhairwe, M Bresser, F Vanobberghen, ... The lancet HIV 7 (11), e752-e761, 2020 | 26 | 2020 |
| Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial M Trøseid, JR Arribas, L Assoumou, AR Holten, J Poissy, V Terzić, ... Critical care 27 (1), 9, 2023 | 25 | 2023 |
| Engagement in care, viral suppression, drug resistance, and reasons for nonengagement after home-based same-day antiretroviral therapy initiation in Lesotho: a two-year follow … A Amstutz, JA Brown, I Ringera, J Muhairwe, TI Lejone, T Klimkait, ... Clinical Infectious Diseases 71 (10), 2608-2614, 2020 | 25 | 2020 |
| Premature discontinuation of prospective clinical studies approved by a research ethics committee–A comparison of randomised and non-randomised studies A Blümle, S Schandelmaier, P Oeller, B Kasenda, M Briel, E von Elm, ... PLoS One 11 (10), e0165605, 2016 | 25 | 2016 |
| Agreements between industry and academia on publication rights: a retrospective study of protocols and publications of randomized clinical trials B Kasenda, E von Elm, JJ You, A Blümle, Y Tomonaga, R Saccilotto, ... PLoS medicine 13 (6), e1002046, 2016 | 25 | 2016 |
